- Exchange: OTC US
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Diagnostic Kits
Snapshot for GeneNews Ltd (GNWSF)
| Open: | 0.8895 | Day's Range: | 0.8895 - 0.8895 | Volume: | 1,000 |
|---|---|---|---|---|---|
| Previous Close: | 0.9380 | 52wk Range: | 0.4320 - 1.0075 | 1-Yr Rtn: | +18.60% |
Key Statistics for GNWSF
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | - |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 6,866 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 05/27/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for GNWSF
Company Profile & Key Executives for GNWSF
GeneNews Ltd. develops and markets diagnostic kits. The Company produces kits that help diagnose cancer, cardiovascular diseases, central nervous system disorders, and arthritis from a blood sample.
| Rory B RiggsChairman | Heiner DreismannInterim CEO |
| Gailina Jiahsin LiewPresident/COO/Secy/Gen Counsel | Leslie AuldCFO/Treasurer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
GNWSF News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page